Status:
COMPLETED
Efficacy and Safety of the Combination of Ten Elements for 6 Months in Patients With Diabetic Neuropathy : A Pilot Study
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Diabetic Neuropathies
Diabetes Mellitus
Eligibility:
FEMALE
Phase:
NA
Brief Summary
To investigate the efficacy of Superoxide Dismutase (SOD, 70 UI), Palmitoylethanolamide (PEA, 300 mg) Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), Nic...
Detailed Description
To investigate the efficacy of Superoxide Dismutase (SOD, 70 UI), Palmitoylethanolamide (PEA, 300 mg) Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), Nic...
Eligibility Criteria
Inclusion
- on metformin therapy for at least 4 years
- diabetes mellitus type 2 with diabetic neuropathy
- painful neuropathy
Exclusion
- healthy
- without diabetic neuropathy
- pregant
Key Trial Info
Start Date :
January 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05984771
Start Date
January 10 2021
End Date
June 30 2022
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University General Hospital AHEPA
Thessaloniki, Thessaloniki, Greece, 54621